CureVac N.V. logo
CureVac N.V. CVAC

Quartalsbericht 2022-Q2
hinzugefügt 18.08.2022

report update icon

CureVac N.V. Langfristiger Schuldenstrom 2011-2026 | CVAC

Langfristiger Schuldenstrom Jährlich CureVac N.V.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.47 M 3.23 M - - - - - - - - -

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
3.47 M 3.23 M 3.35 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.79 -1.15 % $ 4.31 M chinaChina
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.49 0.58 % $ 1.04 B canadaCanada
Frequency Therapeutics Frequency Therapeutics
FREQ
2.67 M - - $ 528 M usaUSA
argenx SE argenx SE
ARGX
6.53 M $ 700.45 -1.19 % $ 25 B niderlandNiderland
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.6 1.41 % $ 8.66 B australiaAustralia
Grifols, S.A. Grifols, S.A.
GRFS
117 M $ 7.81 -2.01 % $ 6.83 B spainSpain
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 225.98 -1.32 % $ 5 B danmarkDanmark
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
1.1 M $ 4.13 -5.06 % $ 105 M schweizSchweiz
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
BioCardia BioCardia
BCDA
333 K $ 1.26 -0.79 % $ 26.7 M usaUSA
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
1.6 M $ 14.2 -0.7 % $ 208 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 91.19 1.21 % $ 27.2 B germanyGermany
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.44 -1.37 % $ 367 M britainBritain
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 6.68 -4.57 % $ 183 M israelIsrael
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
11 K - - $ 521 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.54 -5.22 % $ 16 M usaUSA
Certara Certara
CERT
3.92 M $ 6.67 1.6 % $ 1.07 B usaUSA
Athira Pharma Athira Pharma
ATHA
414 K - - $ 269 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.6 -4.0 % $ 7.83 B israelIsrael
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
549 K - -2.5 % $ 5.88 M usaUSA